ARTICLE | Clinical News
Tykerb: Phase III data
May 6, 2013 7:00 AM UTC
GlaxoSmithKline disclosed in its 1Q13 earnings that the double-blind, international Phase III LOGiC trial in about 545 patients with locally advanced, unresectable or metastatic HER2-positive gastric ...